DuPont Sells Aramids Division for $1.8 Billion to Refine Portfolio
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 29 2025
0mins
Source: Benzinga
DuPont's Sale of Aramids Business
- Transaction Details: DuPont de Nemours, Inc. has agreed to sell its Aramids business, which includes the Kevlar and Nomex brands, to Arclin for approximately $1.8 billion. The deal is expected to close in the first quarter of 2026, pending regulatory approvals.
- Financial Breakdown: Upon closing, DuPont will receive around $1.2 billion in cash before taxes, a $300 million note, and a 17.5% equity stake in the future Arclin business.
Strategic Implications
- CEO's Statement: Lori Koch, DuPont’s CEO, stated that this divestiture aligns with the company's strategy to refine its portfolio and enhance profitability. The deal is anticipated to provide significant cash for reinvestment and allow shareholders to benefit from Arclin’s growth.
- Impact on Workforce and Revenue: The Aramids division employs about 1,900 people and generated $1.3 billion in revenue in 2024. DuPont confirmed that this sale will not affect the planned spinoff of its electronics unit, Qnity, scheduled for November 1, 2025.
Market Context
- Company Outlook: Earlier this month, DuPont raised its outlook due to strong demand across various end markets, indicating a shift towards higher-growth segments.
- Advisors Involved: Centerview Partners and Goldman Sachs advised DuPont on the transaction, while Skadden, Arps, Slate, Meagher & Flom provided legal counsel. Arclin and TJC were advised by Piper Sandler and Kirkland & Ellis.
Stock Performance
- Current Trading Status: DuPont's shares were trading down by 0.35% to $77.36 in premarket trading at the last check on Friday. Investors are also monitoring related ETFs, including the Materials Select Sector SPDR Fund (XLB) and the iShares U.S. Basic Materials ETF (IYM).
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CC
Wall Street analysts forecast CC stock price to fall
7 Analyst Rating
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 20.370
Low
13.00
Averages
16.14
High
19.00
Current: 20.370
Low
13.00
Averages
16.14
High
19.00
About CC
The Chemours Company provides industrial and specialty chemical products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. The Company’s segments include Titanium Technologies, Thermal & Specialized Solutions and Advanced Performance Materials. The Titanium Technologies segment is a provider of titanium dioxide pigment, a premium white pigment used to deliver whiteness, brightness, opacity and protection in various applications. The Thermal & Specialized Solutions segment is a provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a provider of high-end polymers and advanced materials. Its flagship products include brands such as Opteon, Freon, Ti-Pure, Nafion, Teflon, Viton, and Krytox. The Company serves over 2,700 customers in approximately 110 countries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Middle East Conflict Disrupts Global Markets
- Supply Chain Strain: The Middle East conflict has tightened the supply of key commodities, particularly oil and fertilizers, with BMO analysts noting that nitrogen prices have risen about 30% since the conflict began, directly impacting agricultural production.
- Oil Price Volatility: Although crude prices briefly surged toward $120 per barrel, the market reaction remains relatively muted, with BMO analysts arguing that current oil prices do not fully reflect the supply risks, potentially leading to further price increases in the future.
- Chemical Market Pressure: The Middle East accounts for about 15% of global polyethylene production, and any supply disruptions could rapidly tighten the market; BMO analysts also highlighted rising polypropylene prices, indicating strong pricing momentum.
- Battery Production Risks: Sulfur shortages could disrupt lithium refining, with BMO analysts warning that the electric vehicle sector's reliance on sulfur makes it vulnerable to supply crises, particularly affecting nickel extraction processes.
See More
Chemours Completes $700 Million Private Offering of 7.875% Senior Unsecured Notes
- Bond Offering Completion: Chemours successfully completed a private offering of $700 million in 7.875% senior unsecured notes, which is expected to enhance the company's capital structure and provide financial flexibility.
- Debt Redemption: The net proceeds from this offering will be used to redeem $188 million of 5.750% senior notes, with a total redemption price of approximately $189.8 million, thereby reducing future interest burdens and improving financial health.
- Future Redemption Plans: Chemours intends to use the remaining proceeds to redeem outstanding 5.375% senior notes, with an estimated total redemption price of approximately $500.3 million, further optimizing the company's debt structure and lowering financing costs.
- Compliance and Market Positioning: This bond issuance complies with exemptions under the Securities Act of 1933, offered only to qualified institutional buyers, demonstrating Chemours' compliance in capital markets and its attractiveness to investors.
See More
Chemours Completes $700 Million Private Offering of 7.875% Senior Unsecured Notes
- Bond Offering Completed: Chemours successfully completed a private offering of $700 million in 7.875% senior unsecured notes, which is expected to strengthen the company's capital structure and provide funding for future investments.
- Redemption Plan Initiated: The company will use the net proceeds from this offering along with cash on hand to redeem $188 million of its 5.750% senior notes, with a redemption price of approximately $189.8 million, reflecting Chemours' proactive approach to reducing debt costs.
- Future Redemption Expectations: The remaining net proceeds are expected to be used to redeem the outstanding 5.375% senior notes due 2027 for an aggregate redemption price of approximately $500.3 million, further optimizing the company's debt structure and lowering interest expenses.
- Compliance Statement: The notes were not registered under the Securities Act and were offered only to qualified institutional buyers and non-U.S. persons, ensuring compliance and mitigating potential legal risks.
See More
Chemours Under Investigation for Securities Fraud Claims
- Investigation Launched: Pomerantz LLP is investigating Chemours and its executives for potential securities fraud and other unlawful business practices, aiming to protect investor rights and possibly leading to legal liabilities for the company.
- Financial Impact: Chemours reported on February 19, 2026, that its 2025 EBITDA was negatively impacted by a one-time inventory charge in its Advanced Performance Materials segment, indicating short-term cyclical headwinds in the market.
- Stock Price Volatility: Following the earnings report, Chemours' stock price fell by $3.37, or 16.51%, closing at $17.04 per share on February 20, 2026, reflecting market concerns over the company's financial health.
- Legal Context: Pomerantz LLP, a prominent securities class action law firm with over 85 years of experience, focuses on advocating for victims of securities fraud and corporate misconduct, which could significantly impact Chemours' future litigation outcomes.
See More
Chemours Prices $700 Million Offering of 7.875% Senior Notes
- Increased Offering Size: Chemours announced an increase in its offering of 7.875% senior notes from the initially planned $600 million to $700 million, reflecting strong market confidence in its financing needs, with the offering expected to close on March 12, 2026.
- Interest Rate and Maturity: The new notes will mature in 2034 with an annual interest rate of 7.875%, paying interest semi-annually starting September 15, 2026, which will provide Chemours with stable cash inflows to support its operations.
- Clear Use of Proceeds: Chemours intends to use the net proceeds from this offering to redeem its outstanding 5.375% senior notes due 2027 and partially redeem its 5.750% senior notes due 2028, aiming to reduce financial costs and optimize its capital structure, thereby enhancing financial flexibility.
- Compliance and Market Positioning: The notes are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, indicating Chemours' compliance in the capital markets and its appeal to institutional investors.
See More
Investigation into Chemours Company for Securities Fraud
- Investigation Launched: Pomerantz LLP is investigating whether Chemours Company and its executives have engaged in securities fraud or other unlawful business practices, aiming to protect investor rights and potentially initiate a class action lawsuit.
- Financial Impact: Chemours reported on February 19, 2026, that its 2025 EBITDA was negatively impacted by a one-time inventory charge in its Advanced Performance Materials segment, indicating short-term cyclical headwinds in the market.
- Stock Price Volatility: Following the earnings report, Chemours's stock price fell by $3.37, or 16.51%, closing at $17.04 per share on February 20, 2026, reflecting market concerns over the company's financial health.
- Legal Context: Pomerantz LLP, a prominent firm in securities and antitrust class litigation with over 85 years of experience, is dedicated to fighting for the rights of victims of securities fraud and corporate misconduct, which could significantly impact Chemours's legal outlook.
See More
Middle East Conflict Disrupts Global Markets
- Supply Chain Strain: The Middle East conflict has tightened the supply of key commodities, particularly oil and fertilizers, with BMO analysts noting that nitrogen prices have risen about 30% since the conflict began, directly impacting agricultural production.
- Oil Price Volatility: Although crude prices briefly surged toward $120 per barrel, the market reaction remains relatively muted, with BMO analysts arguing that current oil prices do not fully reflect the supply risks, potentially leading to further price increases in the future.
- Chemical Market Pressure: The Middle East accounts for about 15% of global polyethylene production, and any supply disruptions could rapidly tighten the market; BMO analysts also highlighted rising polypropylene prices, indicating strong pricing momentum.
- Battery Production Risks: Sulfur shortages could disrupt lithium refining, with BMO analysts warning that the electric vehicle sector's reliance on sulfur makes it vulnerable to supply crises, particularly affecting nickel extraction processes.
See More
Chemours Completes $700 Million Private Offering of 7.875% Senior Unsecured Notes
- Bond Offering Completion: Chemours successfully completed a private offering of $700 million in 7.875% senior unsecured notes, which is expected to enhance the company's capital structure and provide financial flexibility.
- Debt Redemption: The net proceeds from this offering will be used to redeem $188 million of 5.750% senior notes, with a total redemption price of approximately $189.8 million, thereby reducing future interest burdens and improving financial health.
- Future Redemption Plans: Chemours intends to use the remaining proceeds to redeem outstanding 5.375% senior notes, with an estimated total redemption price of approximately $500.3 million, further optimizing the company's debt structure and lowering financing costs.
- Compliance and Market Positioning: This bond issuance complies with exemptions under the Securities Act of 1933, offered only to qualified institutional buyers, demonstrating Chemours' compliance in capital markets and its attractiveness to investors.
See More
Chemours Completes $700 Million Private Offering of 7.875% Senior Unsecured Notes
- Bond Offering Completed: Chemours successfully completed a private offering of $700 million in 7.875% senior unsecured notes, which is expected to strengthen the company's capital structure and provide funding for future investments.
- Redemption Plan Initiated: The company will use the net proceeds from this offering along with cash on hand to redeem $188 million of its 5.750% senior notes, with a redemption price of approximately $189.8 million, reflecting Chemours' proactive approach to reducing debt costs.
- Future Redemption Expectations: The remaining net proceeds are expected to be used to redeem the outstanding 5.375% senior notes due 2027 for an aggregate redemption price of approximately $500.3 million, further optimizing the company's debt structure and lowering interest expenses.
- Compliance Statement: The notes were not registered under the Securities Act and were offered only to qualified institutional buyers and non-U.S. persons, ensuring compliance and mitigating potential legal risks.
See More
Chemours Under Investigation for Securities Fraud Claims
- Investigation Launched: Pomerantz LLP is investigating Chemours and its executives for potential securities fraud and other unlawful business practices, aiming to protect investor rights and possibly leading to legal liabilities for the company.
- Financial Impact: Chemours reported on February 19, 2026, that its 2025 EBITDA was negatively impacted by a one-time inventory charge in its Advanced Performance Materials segment, indicating short-term cyclical headwinds in the market.
- Stock Price Volatility: Following the earnings report, Chemours' stock price fell by $3.37, or 16.51%, closing at $17.04 per share on February 20, 2026, reflecting market concerns over the company's financial health.
- Legal Context: Pomerantz LLP, a prominent securities class action law firm with over 85 years of experience, focuses on advocating for victims of securities fraud and corporate misconduct, which could significantly impact Chemours' future litigation outcomes.
See More
Chemours Prices $700 Million Offering of 7.875% Senior Notes
- Increased Offering Size: Chemours announced an increase in its offering of 7.875% senior notes from the initially planned $600 million to $700 million, reflecting strong market confidence in its financing needs, with the offering expected to close on March 12, 2026.
- Interest Rate and Maturity: The new notes will mature in 2034 with an annual interest rate of 7.875%, paying interest semi-annually starting September 15, 2026, which will provide Chemours with stable cash inflows to support its operations.
- Clear Use of Proceeds: Chemours intends to use the net proceeds from this offering to redeem its outstanding 5.375% senior notes due 2027 and partially redeem its 5.750% senior notes due 2028, aiming to reduce financial costs and optimize its capital structure, thereby enhancing financial flexibility.
- Compliance and Market Positioning: The notes are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, indicating Chemours' compliance in the capital markets and its appeal to institutional investors.
See More
Investigation into Chemours Company for Securities Fraud
- Investigation Launched: Pomerantz LLP is investigating whether Chemours Company and its executives have engaged in securities fraud or other unlawful business practices, aiming to protect investor rights and potentially initiate a class action lawsuit.
- Financial Impact: Chemours reported on February 19, 2026, that its 2025 EBITDA was negatively impacted by a one-time inventory charge in its Advanced Performance Materials segment, indicating short-term cyclical headwinds in the market.
- Stock Price Volatility: Following the earnings report, Chemours's stock price fell by $3.37, or 16.51%, closing at $17.04 per share on February 20, 2026, reflecting market concerns over the company's financial health.
- Legal Context: Pomerantz LLP, a prominent firm in securities and antitrust class litigation with over 85 years of experience, is dedicated to fighting for the rights of victims of securities fraud and corporate misconduct, which could significantly impact Chemours's legal outlook.
See More
